BA
IMMU

BlackRock Advisors’s Immunomedics Inc IMMU Stock Holding History

BlackRock Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$211K Sell
57,576
-61,481
-52% -$182K ﹤0.01% 2692
2016
Q3 		$386K Buy
119,057
+74,168
+165% +$207K ﹤0.01% 2313
2016
Q2 		$104K Sell
44,889
-904
-2% -$3.02K ﹤0.01% 2947
2016
Q1 		$114K Hold
45,793
– – ﹤0.01% 2857
2015
Q4 		$141K Sell
45,793
-18,560
-29% -$51.8K ﹤0.01% 2764
2015
Q3 		$111K Sell
64,353
-1,682
-3% -$4.29K ﹤0.01% 3049
2015
Q2 		$268K Buy
66,035
+7,682
+13% +$31.4K ﹤0.01% 2619
2015
Q1 		$223K Buy
58,353
+8,547
+17% +$37.2K ﹤0.01% 2613
2014
Q4 		$239K Sell
49,806
-3,059
-6% -$12.1K ﹤0.01% 2519
2014
Q3 		$197K Sell
52,865
-912
-2% -$3.08K ﹤0.01% 2622
2014
Q2 		$196K Sell
53,777
-1,608
-3% -$5.9K ﹤0.01% 2651
2014
Q1 		$233K Buy
55,385
+4,686
+9% +$23.2K ﹤0.01% 2559
2013
Q4 		$233K Buy
50,699
+4,499
+10% +$20K ﹤0.01% 2563
2013
Q3 		$286K Buy
46,200
+733
+2% +$4.22K ﹤0.01% 2312
2013
Q2 		$247K Buy
+45,467
New +$149K ﹤0.01% 2347

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock Advisors's IMMU Position: Q4 2016 in Review

BlackRock Advisors reduced its Immunomedics Inc (IMMU) stake by 52% in Q4 2016, selling an estimated $182K and leaving 57,576 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

BlackRock Advisors first reported a position in IMMU in Q2 2013 and has held it in 15 quarters since. The position peaked at $386K in Q3 2016. 109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • BlackRock Advisors held 57,576 shares of Immunomedics Inc worth $211K as of Q4 2016.
  • BlackRock Advisors sold 61,481 Immunomedics Inc shares in Q4 2016, an estimated $182K.
  • Immunomedics Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2692 holding.
  • BlackRock Advisors first reported a position in Immunomedics Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Immunomedics Inc position peaked at $386K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.